Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency. - Wikidata - wikimedia - TriplyDB

Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency.

Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency.

http://www.wikidata.org/entity/Q34939141

about

Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme Model selection in measures of vascular parameters using dynamic contrast-enhanced MRI: experimental and clinical applications Contemporary murine models in preclinical astrocytoma drug development RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence.Recurrent high-grade glioma: a diagnostic and therapeutic challenge.A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)Integrin targeted therapeutics.Pathway inhibition: emerging molecular targets for treating glioblastoma.Cilengitide-induced temporal variations in transvascular transfer parameters of tumor vasculature in a rat glioma model: identifying potential MRI biomarkers of acute effects.Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5.Cilengitide induces autophagy-mediated cell death in glioma cells.Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma.Gene expression profiling of the anti-glioma effect of Cilengitide.Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models.The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus.Molecular interactions of ErbB1 (EGFR) and integrin-β1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance.Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome Combining molecular targeted agents with radiation therapy for malignant gliomas Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology Group.In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines Integrins: versatile receptors controlling melanocyte adhesion, migration and proliferation.Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?A novel treatment for glioblastoma: integrin inhibition.Antiangiogenic therapies in glioblastoma multiforme.Advances in malignant glioma drug discovery.Cilengitide: a prototypic integrin inhibitor for the treatment of glioblastoma and other malignancies.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer.αv-Integrin isoform expression in primary human tumors and brain metastases.Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor.Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors.Acute Temporal Changes of MRI-Tracked Tumor Vascular Parameters after Combined Anti-angiogenic and Radiation Treatments in a Rat Glioma Model: Identifying Signatures of Synergism.Adhesion molecules and the extracellular matrix as drug targets for glioma.Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology.Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.The effect of cilengitide in combination with irradiation and chemotherapy in head and neck squamous cell carcinoma cell lines.Cilengitide response in ultra-low passage glioblastoma cell lines: relation to molecular markers.

P2860

Q26999917-ABEF5DD9-7880-4CF2-9B9C-113737A30EDF Q27013660-DF18A876-7F22-412B-B704-CC604702398E Q27026937-A08641FF-DC3B-4A8F-8550-A762C6FBCED5 Q30316434-9CD2388A-B5D5-4506-AFF5-8F6A606D4F16 Q33807228-E120E17B-22F1-459F-BF73-3025F9BAD94F Q33864058-D41393E6-DC41-40A8-97BF-088A764FA75D Q34269566-CDE64AAF-2B13-411E-BCEC-FD4C72D00B8A Q34912684-885587BA-A51C-4A0A-88FB-E2309829242C Q35021359-F8033155-458F-4175-9328-478D24C67DC4 Q35078406-39EFCECB-CB0F-437F-9D55-CCDB28B2BDFF Q35111316-78F7D8E0-CD6D-4034-9DA5-B8955DA62534 Q35133418-0CC7CE0B-E549-4AD5-AF3C-00DCC740C7DC Q35788615-E63137FB-B188-4135-882A-3EB068BDD86C Q36103026-882644B5-A6F8-4F23-9F56-250CD2C65E7F Q36824282-D1CA274C-D9BD-45CB-96CB-127D15BD57F1 Q36838793-4087CAE5-7CC1-454A-9B93-65803355FF5F Q36884277-3C93E15B-F8C0-406A-B358-39A1A15A4432 Q36887446-F2ABFE63-FAED-4DCA-932E-450EF2ED61A0 Q37021563-8DA2D40C-BC29-462B-8AB6-7E8C59122C5D Q37046781-279D09E1-6D87-4B7F-86CF-FF4209AD255F Q37099594-FCB4515A-2C07-4F04-A55E-1DFE3350EFBD Q37187676-C8766111-D329-42A9-8273-067B1EAD0A72 Q37277108-5F75DAA7-A574-49A1-97B5-E407B70A3791 Q37810633-A92C62F3-8451-44D3-9B17-407701D38893 Q37993124-7205CD47-5818-44E1-9308-65EC77793899 Q37997092-B30DC208-CC44-4D82-AF5C-2488AE581C5D Q38010802-83483CA4-68E3-42B6-8375-9F43E6F7E455 Q38014949-14DDB407-E120-4007-B535-69F595A9DC51 Q38032282-9070DA07-89F7-428F-ACC1-6A97CF1902D1 Q38108186-142AF954-4103-4E2A-A678-66D1602B1B44 Q38242534-B9733BA0-CE01-4C02-829C-90795D7A37DA Q38396834-1756A632-72C7-4F3A-9A56-54A08BEFDD40 Q38398188-12F83D5C-E60B-45E7-BC15-E44FF640DCC9 Q38399145-AB25655B-C24C-498C-BD46-F3688A4A187C Q38724990-E2D66A50-6C77-468B-BD4A-4EDE98E24152 Q38780522-2487054E-9C2C-4479-AE9B-ECCC60EB7FAA Q38869424-6286C850-E0DB-4041-BDC6-1604AEE4B426 Q38940698-68B69BE6-DB24-4836-B095-1EA4D8963C40 Q39021996-1BFAE31D-9DF0-48A4-914D-87C7A95942CC Q39142115-667C6907-9906-4D64-A518-3ADAA4B4EEB6

P2860

Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency.

http://www.wikidata.org/entity/Q34939141

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Radiation sensitization of gli ...... ticipated schedule-dependency.

@ast

Radiation sensitization of gli ...... ticipated schedule-dependency.

@en

Radiation sensitization of gli ...... ticipated schedule-dependency.

@nl

type

label

Radiation sensitization of gli ...... ticipated schedule-dependency.

@ast

Radiation sensitization of gli ...... ticipated schedule-dependency.

@en

Radiation sensitization of gli ...... ticipated schedule-dependency.

@nl

prefLabel

Radiation sensitization of gli ...... ticipated schedule-dependency.

@ast

Radiation sensitization of gli ...... ticipated schedule-dependency.

@en

Radiation sensitization of gli ...... ticipated schedule-dependency.

@nl

P1433

Q34939141-E7F50ECD-5DDA-457B-8C76-DE15C54EB177

P1476

Q34939141-ED4351DD-FEA6-4E32-90DA-C1A68C5B3F45

P2093

Q34939141-06BFD23A-A8D4-4A0F-8290-42A723C9980F

Q34939141-14D8EFAD-5DB7-4822-A3AE-95D85C8EEC9D

Q34939141-23AAA116-DEFC-4EE9-90F2-AA38D36BDAC0

Q34939141-260DEC60-32DB-45E4-8B40-32BE694D2253

Q34939141-7436BF13-8958-49C2-AF50-2C89597C9F07

Q34939141-8036616F-129E-4BA5-9F9E-E98722060953

Q34939141-8A5CA7B3-9067-4288-B37C-1C41D4C9EB5F

Q34939141-A56CAE1E-615D-4E60-BD1A-490C602809CE

Q34939141-B181E20E-2361-42AB-A7B7-DA51CDC37436

Q34939141-DA9C6B4A-6041-4C3D-9E30-3CB9F7DB4751

P2860

Q34939141-0FD06872-B603-4D1A-AD83-83AF831D4C94

Q34939141-203FC80C-6F71-468A-9DEF-1B9962D87EDE

Q34939141-2909F3C3-4E8E-47B1-9EF0-EC22ACAF6219

Q34939141-2B5E41B3-454C-4B90-B006-FE519CB29DCB

Q34939141-2DD08FBC-04F4-4F91-9A7D-00E274325524

Q34939141-3AAC6458-B4CE-426F-BF2A-1399E37B14E2

Q34939141-44F51384-30F9-4E3E-A0C0-07E90AA7E5E0

Q34939141-553E4BE9-5005-4154-AB0E-E25316D46464

Q34939141-790015A3-738A-48A9-897F-F1D78C68F70B

Q34939141-7E3213E5-35EE-4CCB-8E93-1560BE2B3F1A

P304

Q34939141-85FE98E8-A23B-46DF-BECB-EEA074E2D7F6

P31

Q34939141-2F6EE7B9-4D4D-4963-B329-8AAE96C59D0E

P356

Q34939141-0793655B-2643-47EA-AA89-4A81533C1D61

P433

Q34939141-DF346F68-3B41-4277-93C0-D307B5279A4B

P478

Q34939141-301E081F-91B0-45FB-A72E-AF6EF5D233EF

P50

Q34939141-C1AEF061-0822-47B0-B540-50C7CD752585

P577

Q34939141-B44F32D7-50AE-4ECF-9648-799E061471BD

P5875

Q34939141-8C40614F-CA49-473D-9479-6D1A62295554

P698

Q34939141-DD979DBE-980F-4342-B9EF-6E57A4136277

P356

P1433

International Journal of Cancer

P1476

Radiation sensitization of gli ...... ticipated schedule-dependency.

@en

P2093

Berend Neuteboom

http://www.w3.org/2001/XMLSchema#string

Diane Hahn

http://www.w3.org/2001/XMLSchema#string

Jessica L Rennert

http://www.w3.org/2001/XMLSchema#string

Kevin Nelson

http://www.w3.org/2001/XMLSchema#string

Michael E Berens

http://www.w3.org/2001/XMLSchema#string

Nancy Lemke

http://www.w3.org/2001/XMLSchema#string

Simon L Goodman

http://www.w3.org/2001/XMLSchema#string

Stephen L Brown

http://www.w3.org/2001/XMLSchema#string

Susan Finniss

http://www.w3.org/2001/XMLSchema#string

Tom Mikkelsen

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation and mechanisms of mammalian double-strand break repair

Genes expressed in human tumor endothelium

Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand

The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis

Integrins: bidirectional, allosteric signaling machines

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

Cancer statistics, 2005

Requirement of vascular integrin alpha v beta 3 for angiogenesis

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis.

P304

2719-2727

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.24240

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23986859

http://www.w3.org/2001/XMLSchema#string

P698

19199360

http://www.w3.org/2001/XMLSchema#string